Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
about
Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancerβ-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cellsHeterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assayA comprehensive molecular interaction map for rheumatoid arthritis.Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapyPatterns of expression of DNA repair genes and relapse from melanoma.Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assayDifferences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST)Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selectionMolecular chess? Hallmarks of anti-cancer drug resistanceDNA microarray reveals different pathways responding to paclitaxel and docetaxel in non-small cell lung cancer cell line.Aurora B expression modulates paclitaxel response in non-small cell lung cancer.Identification of markers of prostate cancer progression using candidate gene expression.[Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing gene 1 in lung cancer cell A549/DDP].Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.
P2860
Q26863490-59228FB9-2F44-42CB-ADAC-CEBF351A686CQ28387031-7BDFAAD6-F058-4028-B7DD-A681F79EA4A9Q28389114-AF56C212-89C1-4AB2-894D-B266043CCDAAQ33564313-DBEF28E4-9684-4D08-BF1B-9BB9EE83B841Q34122814-59DFBEEE-2011-4AB2-95EC-23229AFDDD0EQ34273603-66BAB36D-0FEA-4B28-8DD2-4B02AFE431BFQ34795754-3B765026-2A79-4187-BCB7-86E9338AF455Q35667895-E926E3C9-E458-45F9-A478-F391D2D811C3Q35677556-84D9302C-5BEB-468C-9D2A-D574F26428B0Q36240941-660FBBD8-E4EB-4AE3-B767-4D26570B4532Q37054550-9F7B85BE-63B2-4D21-B89D-043AE0458C9EQ38720934-1FA4E4AA-6BD6-49F5-8B14-658B83A9205BQ40177572-B5B47FCE-79B0-481D-BBBF-0D702E1C618EQ42907465-27F4C36F-B694-42D0-ABE6-E649077FBB5AQ53198392-6CE8C3DA-C77A-49A7-86DD-F5EEFEDB3CA4Q54290367-08F075C6-C9F9-4009-BB84-88FDB7140378
P2860
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resistance gene expression det ...... small cell lung cancer (NSCLC)
@en
Resistance gene expression det ...... of non-small cell lung cancer
@nl
type
label
Resistance gene expression det ...... small cell lung cancer (NSCLC)
@en
Resistance gene expression det ...... of non-small cell lung cancer
@nl
prefLabel
Resistance gene expression det ...... small cell lung cancer (NSCLC)
@en
Resistance gene expression det ...... of non-small cell lung cancer
@nl
P2093
P2860
P356
P1433
P1476
Resistance gene expression det ...... small cell lung cancer (NSCLC)
@en
P2093
Ajit Narayanan
Bruce Addis
Dennis Yiannakis
Francis G Gabriel
Ian A Cree
Joe Rahamim
Katharine Peregrin
Khalid Amer
Louise A Knight
Mark E Smith
P2860
P2888
P356
10.1186/1471-2407-9-300
P407
P577
2009-08-27T00:00:00Z
P5875
P6179
1032503214